http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-109161597-B
Outgoing Links
Predicate | Object |
---|---|
classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-158 |
classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-6886 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-6886 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-11 |
filingDate | 2018-11-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate | 2019-03-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationDate | 2019-03-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | CN-109161597-B |
titleOfInvention | It is a kind of for the excretion body source property gene mRNA marker group of prostatic cancer early diagnosis and its application |
abstract | The present invention relates to a kind of for the excretion body source property gene mRNA marker group of prostatic cancer early diagnosis and its application, and the marker group includes: excretion body source property TXK gene mRNA, excretion body source property ATM gene mRNA, excretion body source property MAX gene mRNA, excretion body source property STK4 gene mRNA, excretion body source property GRK5 gene mRNA, excretion body source property PDGFA gene mRNA, excretion body source property IL32 gene mRNA, excretion body source property RASSF5 gene mRNA and excretion body source property TOX4 gene mRNA.Marker group, reagent/kit, system and application of the present invention can accurately distinguish Prostate Cancer Subjects and non-Prostate Cancer Subjects (including benign prostatic hyperplasis, prostatitis, normal person etc.), sensitivity, specificity and the accuracy for improving prostatic cancer early diagnosis, to avoid clinically unnecessary aspiration biopsy of prostatic gland. |
priorityDate | 2018-11-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 93.